Blog
Get the latest news about liver diseases and more
Get the latest news about liver diseases and more
We analyze the latest studies carried out regarding post-vacial protection against coronavirus and the appearance of new medications.
Two recent studies carried out with antiviral drugs demonstrate their effectiveness against Coronavirus.
We analyze the need for a third dose of reinforcement against coronavirus and studies published in this regard.
Last studies give light on the duration of the vaccine and the need for reinforcement against the COVID-19.
At the European Congress on Liver Diseases, held at the end of June, an interesting work was presented in relation to fatty liver.
Although numerous studies have been published on COVID-19, works regarding the durability of post-vaccination protection are scarce.
In addition to vaccines there are other methods to reduce the possibility of coronavirus infection.
A study in Journal of Hepatology on the recommended diet for patients with fatty liver has recently been published.
23 de August de 2018
27 de July de 2020
21 de October de 2018
It is a chronic progressive liver disease that mainly affects women (90% of cases) from the fourth decade of life.
It is a progressive chronic inflammatory disease of the liver that can lead to liver cirrhosis.
It is the second cause of liver transplantation in the USA and in the next 10 years is expected to be the first cause. It is a serious illness if it is not treated properly.
Hepatitis is an inflammation of the liver, and in the case of hepatitis C, caused by infection with hepatitis C virus (HCV)
It is a liver disease of an inflammatory nature and can develop chronically.
Hepatitis E is an acute inflammatory disease of the liver that can lead to fulminant hepatitis.